Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Operating Leases (2021 - 2023)

Historic Operating Leases for Dna X (SONM) over the last 3 years, with Q4 2023 value amounting to $55000.0.

  • Dna X's Operating Leases fell 1666.67% to $55000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $55000.0, marking a year-over-year decrease of 1666.67%. This contributed to the annual value of $55000.0 for FY2023, which is 1666.67% down from last year.
  • According to the latest figures from Q4 2023, Dna X's Operating Leases is $55000.0, which was down 1666.67% from $120000.0 recorded in Q3 2023.
  • In the past 5 years, Dna X's Operating Leases registered a high of $1.6 million during Q2 2022, and its lowest value of $55000.0 during Q4 2023.
  • Over the past 3 years, Dna X's median Operating Leases value was $183000.0 (recorded in 2023), while the average stood at $392555.6.
  • Per our database at Business Quant, Dna X's Operating Leases changed by 0.0% in 2022 and then tumbled by 8836.62% in 2023.
  • Dna X's Operating Leases (Quarter) stood at $66000.0 in 2021, then changed by 0.0% to $66000.0 in 2022, then fell by 16.67% to $55000.0 in 2023.
  • Its Operating Leases stands at $55000.0 for Q4 2023, versus $120000.0 for Q3 2023 and $183000.0 for Q2 2023.